Literature DB >> 21285438

Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane.

Suparna Nanua1, Mark Murakami, Jun Xia, David S Grenda, Jill Woloszynek, Marie Strand, Daniel C Link.   

Abstract

Severe congenital neutropenia (SCN) is an inborn disorder of granulopoiesis that in many cases is caused by mutations of the ELANE gene, which encodes neutrophil elastase (NE). Recent data suggest a model in which ELANE mutations result in NE protein misfolding, induction of endoplasmic reticulum (ER) stress, activation of the unfolded protein response (UPR), and ultimately a block in granulocytic differentiation. To test this model, we generated transgenic mice carrying a targeted mutation of Elane (G193X) reproducing a mutation found in SCN. The G193X Elane allele produces a truncated NE protein that is rapidly degraded. Granulocytic precursors from G193X Elane mice, though without significant basal UPR activation, are sensitive to chemical induction of ER stress. Basal and stress granulopoiesis after myeloablative therapy are normal in these mice. Moreover, inaction of protein kinase RNA-like ER kinase (Perk), one of the major sensors of ER stress, either alone or in combination with G193X Elane, had no effect on basal granulopoiesis. However, inhibition of the ER-associated degradation (ERAD) pathway using a proteosome inhibitor resulted in marked neutropenia in G193X Elane. The selective sensitivity of G913X Elane granulocytic cells to ER stress provides new and strong support for the UPR model of disease patho-genesis in SCN.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21285438      PMCID: PMC3072877          DOI: 10.1182/blood-2010-10-311704

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  36 in total

1.  EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome.

Authors:  M Delépine; M Nicolino; T Barrett; M Golamaully; G M Lathrop; C Julier
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

2.  Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia.

Authors:  K Devriendt; A S Kim; G Mathijs; S G Frints; M Schwartz; J J Van Den Oord; G E Verhoef; M A Boogaerts; J P Fryns; D You; M K Rosen; P Vandenberghe
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

3.  Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia.

Authors:  M Germeshausen; H Schulze; M Ballmaier; C Zeidler; K Welte
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

4.  Perk is essential for translational regulation and cell survival during the unfolded protein response.

Authors:  H P Harding; Y Zhang; A Bertolotti; H Zeng; D Ron
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

5.  Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia.

Authors:  D C Dale; R E Person; A A Bolyard; A G Aprikyan; C Bos; M A Bonilla; L A Boxer; G Kannourakis; C Zeidler; K Welte; K F Benson; M Horwitz
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

6.  In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days.

Authors:  Janesh Pillay; Ineke den Braber; Nienke Vrisekoop; Lydia M Kwast; Rob J de Boer; José A M Borghans; Kiki Tesselaar; Leo Koenderman
Journal:  Blood       Date:  2010-04-21       Impact factor: 22.113

7.  Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.

Authors:  Jun Xia; Audrey A Bolyard; Elin Rodger; Steve Stein; Andrew A Aprikyan; David C Dale; Daniel C Link
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

8.  Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia.

Authors:  Phil J Ancliff; Rosemary E Gale; Michael J Watts; Ri Liesner; Ian M Hann; Stephan Strobel; David C Linch
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

9.  The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.

Authors:  Kirsten Neubert; Silke Meister; Katrin Moser; Florian Weisel; Damian Maseda; Kerstin Amann; Carsten Wiethe; Thomas H Winkler; Joachim R Kalden; Rudolf A Manz; Reinhard E Voll
Journal:  Nat Med       Date:  2008-06-08       Impact factor: 53.440

10.  A syndrome with congenital neutropenia and mutations in G6PC3.

Authors:  Kaan Boztug; Giridharan Appaswamy; Angel Ashikov; Alejandro A Schäffer; Ulrich Salzer; Jana Diestelhorst; Manuela Germeshausen; Gudrun Brandes; Jacqueline Lee-Gossler; Fatih Noyan; Anna-Katherina Gatzke; Milen Minkov; Johann Greil; Christian Kratz; Theoni Petropoulou; Isabelle Pellier; Christine Bellanné-Chantelot; Nima Rezaei; Kirsten Mönkemöller; Noha Irani-Hakimeh; Hans Bakker; Rita Gerardy-Schahn; Cornelia Zeidler; Bodo Grimbacher; Karl Welte; Christoph Klein
Journal:  N Engl J Med       Date:  2009-01-01       Impact factor: 91.245

View more
  30 in total

Review 1.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

2.  Normal peripheral blood neutrophil numbers accompanying ELANE whole gene deletion mutation.

Authors:  Marshall S Horwitz; Mercy Y Laurino; Siobán B Keel
Journal:  Blood Adv       Date:  2019-08-27

Review 3.  Severe congenital neutropenias.

Authors:  Julia Skokowa; David C Dale; Ivo P Touw; Cornelia Zeidler; Karl Welte
Journal:  Nat Rev Dis Primers       Date:  2017-06-08       Impact factor: 52.329

4.  A Truncated Granulocyte Colony-stimulating Factor Receptor (G-CSFR) Inhibits Apoptosis Induced by Neutrophil Elastase G185R Mutant: IMPLICATION FOR UNDERSTANDING CSF3R GENE MUTATIONS IN SEVERE CONGENITAL NEUTROPENIA.

Authors:  Yaling Qiu; Yangyang Zhang; Nan Hu; Fan Dong
Journal:  J Biol Chem       Date:  2017-01-10       Impact factor: 5.157

5.  Understanding, treating and avoiding hematological disease: better medicine through mathematics?

Authors:  David C Dale; Michael C Mackey
Journal:  Bull Math Biol       Date:  2014-09-12       Impact factor: 1.758

6.  Serpin B1 defect and increased apoptosis of neutrophils in Cohen syndrome neutropenia.

Authors:  Laurence Duplomb; Julie Rivière; Gaëtan Jego; Romain Da Costa; Arlette Hammann; Jessica Racine; Alain Schmitt; Nathalie Droin; Claude Capron; Marie-Anne Gougerot-Pocidalo; Laurence Dubrez; Bernard Aral; Arnaud Lafon; Patrick Edery; Jamal Ghoumid; Edward Blair; Salima El Chehadeh-Djebbar; Virginie Carmignac; Julien Thevenon; Julien Guy; François Girodon; Jean-Noël Bastie; Laurent Delva; Laurence Faivre; Christel Thauvin-Robinet; Eric Solary
Journal:  J Mol Med (Berl)       Date:  2019-03-07       Impact factor: 4.599

Review 7.  New monogenic disorders identify more pathways to neutropenia: from the clinic to next-generation sequencing.

Authors:  Seth J Corey; Usua Oyarbide
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

8.  Inducible expression of a disease-associated ELANE mutation impairs granulocytic differentiation, without eliciting an unfolded protein response.

Authors:  Bhavuk Garg; Hrishikesh M Mehta; Borwyn Wang; Ralph Kamel; Marshall S Horwitz; Seth J Corey
Journal:  J Biol Chem       Date:  2020-04-16       Impact factor: 5.157

Review 9.  Animal models of human granulocyte diseases.

Authors:  Alejandro A Schäffer; Christoph Klein
Journal:  Hematol Oncol Clin North Am       Date:  2012-10-31       Impact factor: 3.722

Review 10.  ELANE mutations in cyclic and severe congenital neutropenia: genetics and pathophysiology.

Authors:  Marshall S Horwitz; Seth J Corey; H Leighton Grimes; Timothy Tidwell
Journal:  Hematol Oncol Clin North Am       Date:  2012-11-07       Impact factor: 3.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.